Exercise induces a decline in liver malonyl-CoA, an inhibitor of carnitine palmitoyltransferase-1. The purpose of these experiments was to determine whether this decrease in malonyl-CoA is accompanied by an activation of AMP-activated protein kinase (AMPK) and inactivation of acetyl-CoA carboxylase (ACC). Rats were killed at rest, after 10 min of running at 32 m/min up a 15% grade or at 0, 15, or 60 min postexercise after 120 min of running at 16 m/min. There was no significant difference in AMPK and ACC activities after 120 min of exercise, although a trend toward a decrease in ACC and an increase in AMPK was noted 15 min postexercise. After 10 min at 32 m/min, however, maximal ACC activity decreased from 487 ± 27 to 280 ± 39 nmol · g¹ · min¹, and the activation constant for citrate activation of ACC increased from 5.9 to 12.5 mM. AMPK activity increased from a resting value of 4.7 ± 0.4 to 9.8 ± 2.0 pmol · mg¹ · min¹ after exercise. These data provide indirect evidence of phosphorylation and inactivation of liver ACC during heavy exercise. In contrast, the decrease in malonyl-CoA during long-term, low-intensity exercise may occur by mechanisms other than phosphorylation of ACC.

carnitine palmitoyltransferase-1; malonyl-coenzyme A; postexercise ketosis; 3-hydroxybutyrate

This article has been cited by other articles:

				T. P. Solomon, J. M Haus, K. R Kelly, M. D Cook, M. Riccardi, M. Rocco, S. R Kashyap, H. Barkoukis, and J. P Kirwan Randomized trial on the effects of a 7-d low-glycemic diet and exercise intervention on insulin resistance in older obese humans Am. J. Clinical Nutrition, November 1, 2009; 90(5): 1222 - 1229. [Abstract] [Full Text] [PDF]

				J. P. Kirwan, T. P. J. Solomon, D. M. Wojta, M. A. Staten, and J. O. Holloszy Effects of 7 days of exercise training on insulin sensitivity and responsiveness in type 2 diabetes mellitus Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E151 - E156. [Abstract] [Full Text] [PDF]

				R. S. Rector, J. P. Thyfault, R. T. Morris, M. J. Laye, S. J. Borengasser, F. W. Booth, and J. A. Ibdah Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats Am J Physiol Gastrointest Liver Physiol, March 1, 2008; 294(3): G619 - G626. [Abstract] [Full Text] [PDF]

				R. C. Camacho, E. P. Donahue, F. D. James, E. D. Berglund, and D. H. Wasserman Energy state of the liver during short-term and exhaustive exercise in C57BL/6J mice Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E405 - E408. [Abstract] [Full Text] [PDF]

				J. V. Swinnen, A. Beckers, K. Brusselmans, S. Organe, J. Segers, L. Timmermans, F. Vanderhoydonc, L. Deboel, R. Derua, E. Waelkens, et al. Mimicry of a Cellular Low Energy Status Blocks Tumor Cell Anabolism and Suppresses the Malignant Phenotype Cancer Res., March 15, 2005; 65(6): 2441 - 2448. [Abstract] [Full Text] [PDF]

				R. R. Pencek, J. Shearer, R. C. Camacho, F. D. James, D. B. Lacy, P. T. Fueger, E. P. Donahue, W. Snead, and D. H. Wasserman 5-Aminoimidazole-4-Carboxamide-1-{beta}-D-Ribofuranoside Causes Acute Hepatic Insulin Resistance In Vivo Diabetes, February 1, 2005; 54(2): 355 - 360. [Abstract] [Full Text] [PDF]

				R. C. Camacho, R. R. Pencek, D. B. Lacy, F. D. James, E. P. Donahue, and D. H. Wasserman Portal Venous 5-Aminoimidazole-4-Carboxamide-1-{beta}-D-Ribofuranoside Infusion Overcomes Hyperinsulinemic Suppression of Endogenous Glucose Output Diabetes, February 1, 2005; 54(2): 373 - 382. [Abstract] [Full Text] [PDF]

				A. A. Gonzalez, R. Kumar, J. D. Mulligan, A. J. Davis, R. Weindruch, and K. W. Saupe Metabolic adaptations to fasting and chronic caloric restriction in heart, muscle, and liver do not include changes in AMPK activity Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E1032 - E1037. [Abstract] [Full Text] [PDF]

				P. Dobrzyn, A. Dobrzyn, M. Miyazaki, P. Cohen, E. Asilmaz, D. G. Hardie, J. M. Friedman, and J. M. Ntambi Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver PNAS, April 27, 2004; 101(17): 6409 - 6414. [Abstract] [Full Text] [PDF]

				M. A. Iglesias, J.-M. Ye, G. Frangioudakis, A. K. Saha, E. Tomas, N. B. Ruderman, G. J. Cooney, and E. W. Kraegen AICAR Administration Causes an Apparent Enhancement of Muscle and Liver Insulin Action in Insulin-Resistant High-Fat-Fed Rats Diabetes, October 1, 2002; 51(10): 2886 - 2894. [Abstract] [Full Text] [PDF]

				H. Park, V. K. Kaushik, S. Constant, M. Prentki, E. Przybytkowski, N. B. Ruderman, and A. K. Saha Coordinate Regulation of Malonyl-CoA Decarboxylase, sn-Glycerol-3-phosphate Acyltransferase, and Acetyl-CoA Carboxylase by AMP-activated Protein Kinase in Rat Tissues in Response to Exercise J. Biol. Chem., August 30, 2002; 277(36): 32571 - 32577. [Abstract] [Full Text] [PDF]

				J.-M. Lavoie, Y. Fillion, K. Couturier, and P. Corriveau Exercise Effects on Muscle Insulin Signaling and Action: Selected Contribution: Evidence that the decrease in liver glycogen is associated with the exercise-induced increase in IGFBP-1 J Appl Physiol, August 1, 2002; 93(2): 798 - 804. [Abstract] [Full Text] [PDF]

				E. S. Buhl, N. Jessen, R. Pold, T. Ledet, A. Flyvbjerg, S. B. Pedersen, O. Pedersen, O. Schmitz, and S. Lund Long-Term AICAR Administration Reduces Metabolic Disturbances and Lowers Blood Pressure in Rats Displaying Features of the Insulin Resistance Syndrome Diabetes, July 1, 2002; 51(7): 2199 - 2206. [Abstract] [Full Text] [PDF]

				W. W. Winder and D. G. Hardie AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes Am J Physiol Endocrinol Metab, July 1, 1999; 277(1): E1 - E10. [Abstract] [Full Text] [PDF]